Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
about
Pulmonary vasculature in COPD: The silent componentPulmonary hypertension survival effects and treatment options in cystic fibrosisRight ventricular dysfunction in chronic lung diseaseThe safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease.Efficacy of inhaled iloprost in cor pulmonale and severe pulmonary hypertension associated with tuberculous destroyed lung.Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomicsAcute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trialDefective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungsTherapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis.Lung transplantation for pulmonary hypertension.Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary diseasePulmonary Hypertension Secondary to COPD.Pathophysiology and clinical implications of pulmonary arterial enlargement in COPDInhaled treprostinil for the treatment of pulmonary arterial hypertension.Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.COPD-associated pulmonary hypertension: clinical implications and current methods for treatment.The use of iloprost in the treatment of 'out of proportion' pulmonary hypertension in chronic obstructive pulmonary disease.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to lung diseases and/or hypoxia.Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population.Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension.Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series.
P2860
Q26749309-EAC43777-0B59-4759-B962-C9157408A1B0Q26825432-BBB0D0BC-19A8-4D11-85E2-8C3904666A24Q27002670-E36562D9-3F33-4289-BA34-CCBC6D6E25D6Q33738555-FFA7BD92-186B-447F-8520-48A692C79285Q33896324-7B6C4B57-F350-4285-9654-B3AFCD60C6F2Q34343972-308553DD-C5E7-461E-9FA4-B8F4F2C2C174Q34344390-344C6FFD-BCC0-45B9-B032-F1B6E9CC92A7Q34540493-1C16B97D-EABB-4BF8-805B-EC3A7C601EF9Q34585087-DC1A1C90-8930-4859-9071-FCF99AD77503Q34999736-BD525C24-3A49-4A25-A566-ECBEADC182B9Q35290234-4FB15542-DE97-42E7-8F5B-494BAAFA7767Q35412426-BD8C40F8-8FE2-4866-B720-9CB6BB12EF8DQ35665739-3D1702D5-F474-4E6E-BFCC-C6F1B552C5CDQ36221051-7283CBB9-D5ED-43CE-AC55-99D6ADF19427Q37304910-A5138A90-622B-4D46-9B95-67329F7EDE74Q38025723-0845BE66-CE2D-4B65-9785-9AE3A8D062A8Q38538687-64313FF8-83BE-4B17-A8A5-44500FBA5025Q38841456-C6BF1024-CF24-4801-B844-886C579C3173Q40634338-42460DDF-8564-48C8-B46D-67A757C291C9Q41838314-FB3266FF-61A4-4C1C-969F-1B0197852CA9Q44232234-478A9A6D-ABD1-4D12-9ECA-F33795C54D90Q45326440-E1AB42E7-14BD-4D5E-A982-8424168DDC70Q47137930-DB29EE74-0315-4FB3-B871-C09C4A8DE908Q48221297-CDF59707-8426-4F6E-9CAE-012EF8C66F93Q50985276-4E4B96B4-9BD7-48C8-8465-B8E648B7D5EF
P2860
Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@en
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@nl
type
label
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@en
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@nl
prefLabel
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@en
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@nl
P2093
P356
P1433
P1476
Iloprost improves gas exchange ...... obstructive pulmonary disease.
@en
P2093
Gary T Kinasewitz
Mikel Beavin
Tarek A Dernaika
P304
P356
10.1159/000242498
P577
2009-09-25T00:00:00Z